Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Other Non-Current Liabilities of $31.86 million for the quarter ended Jun 30, 2026, down 21.6% from $40.63 million a year earlier and down 15.4% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Other Non-Current Liabilities came in at $378.08 billion, up 13.0% from the prior year.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 552.4% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Other Non-Current Liabilities was $334.66 billion in the year ended Mar 31, 2025, $46.87 million in the year ended Mar 31, 2024 (+33.9%), $35 million in the year ended Mar 31, 2023 (+9.4%) and $32 million in the year ended Mar 31, 2022 (unchanged).
- Quarterly Other Non-Current Liabilities has run from a low of $26.33 million in the quarter ended Dec 31, 2025 to a high of $71.91 million in the quarter ended Sep 30, 2024 over five years.
- On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last six quarters, with an average decline of 9.6% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was the quarter ended Sep 30, 2024, with growth of 67.5%; the weakest was the quarter ended Dec 31, 2025, with a decline of 62.4%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $37.66 million (quarter ended Mar 31, 2026), $26.33 million (quarter ended Dec 31, 2025) and $27.05 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.86 Mn |
| Mar 31, 2026 | 37.66 Mn |
| Dec 31, 2025 | 26.33 Mn |
| Sep 30, 2025 | 27.05 Mn |
| Jun 30, 2025 | 40.63 Mn |
| Mar 31, 2025 | 38.14 Mn |
| Dec 31, 2024 | 70.07 Mn |
| Sep 30, 2024 | 71.91 Mn |
| Jun 30, 2024 | 48.41 Mn |
| Mar 31, 2024 | 47.79 Mn |
| Dec 31, 2023 | 50.32 Mn |
| Sep 30, 2023 | 42.93 Mn |
| Jun 30, 2023 | 41.16 Mn |
| Mar 31, 2023 | 34.65 Mn |
| Dec 31, 2022 | 36.17 Mn |
| Sep 30, 2022 | 35.43 Mn |
| Jun 30, 2022 | 36.08 Mn |
| Mar 31, 2022 | 32.21 Mn |
| Dec 31, 2021 | 35.10 Mn |
| Sep 30, 2021 | 34.23 Mn |
API Access
Dr Reddys Laboratories Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();